These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38298913)

  • 1. Dyschromatopsia: a comprehensive analysis of mechanisms and cutting-edge treatments for color vision deficiency.
    Yang Z; Yan L; Zhang W; Qi J; An W; Yao K
    Front Neurosci; 2024; 18():1265630. PubMed ID: 38298913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy in color vision deficiency: a review.
    El Moussawi Z; Boueiri M; Al-Haddad C
    Int Ophthalmol; 2021 May; 41(5):1917-1927. PubMed ID: 33528822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
    Katz B
    Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia.
    McKyton A; Averbukh E; Marks Ohana D; Levin N; Banin E
    J Neurosci; 2021 Sep; 41(35):7363-7371. PubMed ID: 34349002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options.
    Hirji N; Aboshiha J; Georgiou M; Bainbridge J; Michaelides M
    Ophthalmic Genet; 2018 Apr; 39(2):149-157. PubMed ID: 29303385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seeing color following gene augmentation therapy in achromatopsia.
    McKyton A; Marks Ohana D; Nahmany E; Banin E; Levin N
    Curr Biol; 2023 Aug; 33(16):3489-3494.e2. PubMed ID: 37433300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color vision and color pattern visual evoked cortical potentials in a patient with acquired cerebral dyschromatopsia.
    Adachi-Usami E; Tsukamoto M; Shimada Y
    Doc Ophthalmol; 1995; 90(3):259-69. PubMed ID: 8846734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa.
    Yue L; Castillo J; Gonzalez AC; Neitz J; Humayun MS
    Ophthalmology; 2021 Mar; 128(3):453-462. PubMed ID: 32858064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color vision.
    Carroll J; Conway BR
    Handb Clin Neurol; 2021; 178():131-153. PubMed ID: 33832674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of
    Ofri R; Averbukh E; Ezra-Elia R; Ross M; Honig H; Obolensky A; Rosov A; Hauswirth WW; Gootwine E; Banin E
    Hum Gene Ther; 2018 Dec; 29(12):1376-1386. PubMed ID: 29926749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color vision defects in pigmentary retinal dystrophy.
    Okajima O; Tanino T; Okamoto M
    Jpn J Ophthalmol; 1982; 26(3):292-301. PubMed ID: 6984101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics of congenital color vision defects. II. Rare types of color blindness].
    Krawczyński MR
    Klin Oczna; 1995; 97(1-2):39-43. PubMed ID: 7637312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Color Blindness.
    Hassall MM; Barnard AR; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):543-551. PubMed ID: 29259520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A demonstration of cone function plasticity after gene therapy in achromatopsia.
    Farahbakhsh M; Anderson EJ; Maimon-Mor RO; Rider A; Greenwood JA; Hirji N; Zaman S; Jones PR; Schwarzkopf DS; Rees G; Michaelides M; Dekker TM
    Brain; 2022 Nov; 145(11):3803-3815. PubMed ID: 35998912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
    Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
    JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of color blindness for microscopists: guidelines and tools for accommodating and coping with color vision deficiency.
    Keene DR
    Microsc Microanal; 2015 Apr; 21(2):279-89. PubMed ID: 25739321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Color Blindness in Iranian Students: A Meta-analysis.
    Rezaei L; Hawasi E; Salari N; Mohammadi M
    J Ophthalmic Vis Res; 2022; 17(3):413-423. PubMed ID: 36160104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired color vision deficiency.
    Simunovic MP
    Surv Ophthalmol; 2016; 61(2):132-55. PubMed ID: 26656928
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.